Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma.
Journal
Current opinion in allergy and clinical immunology
ISSN: 1473-6322
Titre abrégé: Curr Opin Allergy Clin Immunol
Pays: United States
ID NLM: 100936359
Informations de publication
Date de publication:
31 Jan 2024
31 Jan 2024
Historique:
medline:
31
1
2024
pubmed:
31
1
2024
entrez:
31
1
2024
Statut:
aheadofprint
Résumé
Allergic bronchopulmonary aspergillosis (ABPA) can complicate the natural history of asthmatic patients, especially the more severe ones, worsening disease control and increasing the need for therapies, steroids in particular, and medical care. The aim of the present review is to summarize the latest epidemiological data related to the relationship between asthma and ABPA and to offer a summary of the most recent strategies that could potentially facilitate in the identification of ABPA in asthmatic patients. In the last years, great efforts have been made by researchers worldwide to provide reliable epidemiological data on fungal sensitization and ABPA, especially in severe asthma patients both in adult and pediatric population. Data differ depending on the geographical area and population studied, but pooled data show a concerning 11% of severe asthma patients having ABPA and one out of four asthmatic patients being sensitized to fungi, Aspergillus fumigatus in particular. Reliable epidemiological data and advances in the diagnostic procedures can facilitate the detection of ABPA among asthmatic patients, improving the management of a still under-recognized and challenging condition.
Identifiants
pubmed: 38295145
doi: 10.1097/ACI.0000000000000971
pii: 00130832-990000000-00104
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
Références
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. 2023.
Vitte J, Michel M, Malinovschi A, et al. EAACI Task Force on Allergic Bronchopulmonary Aspergillosis Fungal exposome, human health, and unmet needs: a 2022 update with special focus on allergy. Allergy 2022; 77:3199–3216.
Maule M, Olivieri B, Guarnieri G, et al. Hidden comorbidities in asthma: a perspective for a personalized approach. J Clin Med 2023; 12:2294.
Agarwal R, Muthu V, Sehgal IS, et al. Prevalence of aspergillus sensitization and allergic bronchopulmonary aspergillosis in adults with bronchial asthma: a systematic review of global data. J Allergy Clin Immunol Pract 2023; 11:1734.e3–1751.e3.
Hammad H, Lambrecht BN. The basic immunology of asthma. Cell 2021; 184:1469–1485.
Brusselle GG, Koppelman GH. Biologic therapies for severe asthma. N Engl J Med 2022; 386:157–171.
Kanaujia R, Arora A, Chakrabarti A, et al. Occurrence of cystic fibrosis transmembrane conductance regulator gene mutations in patients with allergic bronchopulmonary aspergillosis complicating asthma. Mycopathologia 2022; 187:147–155.
Heung LJ, Wiesner DL, Wang K, et al. Immunity to fungi in the lung. Semin Immunol 2023; 66:101728.
Anees-Hill S, Douglas P, Pashley CH, et al. A systematic review of outdoor airborne fungal spore seasonality across Europe and the implications for health. Sci Total Environ 2022; 818:151716.
Miller RL, Grayson MH, Strothman K. Advances in asthma: New understandings of asthma's natural history, risk factors, underlying mechanisms, and clinical management. J Allergy Clin Immunol 2021; 148:1430–1441.
Okada N, Yamamoto Y, Oguma T, et al. Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-Factor analysis. Allergy 2023; 78:2933–2943.
Moss RB. Diagnosing allergic bronchopulmonary aspergillosis/mycosis: return to lost horizons. J Allergy Clin Immunol 2021; 147:1212–1214.
Agarwal R, Muthu V, Sehgal IS. Relationship between Aspergillus and asthma. Allergol Int 2023; 72:507–520.
Solidoro P, Nicola S, Ridolfi I, et al. Aspergillus-related diseases in a cohort of patients with severe asthma: a SANI single-center report. J Allergy Clin Immunol Pract 2021; 9:2920.e2–2922.e2.
Mistry H, Ajsivinac Soberanis HM, Kyyaly MA, et al. The clinical implications of Aspergillus Fumigatus sensitization in difficult-to-treat asthma patients. J Allergy Clin Immunol Pract 2021; 9:4254.e10–4267.e10.
Wark P, Hussaini S, Holder C, et al. Omalizumab is an effective intervention in severe asthma with fungal sensitization. J Allergy Clin Immunol Pract 2020; 8:3428.e1–3433.e1.
Agarwal R, Sehgal IS, Muthu V, et al. Allergic bronchopulmonary aspergillosis in India. Clin Exp Allergy 2023; 53:751–764.
Soundappan K, Muthu V, Dhooria S, et al. Population prevalence of allergic bronchopulmonary aspergillosis in asthma: an epidemiological study of 43,261 participants from North India. Clin Exp Allergy 2023; 53:777–780.
Muthu V, Sehgal IS, Prasad KT, et al. Epidemiology and outcomes of allergic bronchopulmonary aspergillosis in the elderly. Mycoses 2022; 65:71–78.
Kwizera R, Musaazi J, Meya DB, et al. Burden of fungal asthma in Africa: a systematic review and meta-analysis. PloS One 2019; 14:e0216568.
Agarwal R, Muthu V, Sehgal IS, et al. Aspergillus sensitization and allergic bronchopulmonary aspergillosis in asthmatic children: a systematic review and meta-analysis. Diagn Basel Switz 2023; 13:922.
Oguma T, Taniguchi M, Shimoda T, et al. Allergic bronchopulmonary aspergillosis in Japan: a nationwide survey. Allergol Int 2018; 67:79–84.
Denning DW, Pfavayi LT. Poorly controlled asthma - Easy wins and future prospects for addressing fungal allergy. Allergol Int 2023; 72:493–506.
Caminati M, Feleszko W, Michel M, et al. EAACI Task Force Diagnosis, Management of ABPA Aspergillus fumigatus and personalized medicine: toward a clinically reliable algorithm. Allergy 2022; 77:3476–3477.
Michel M, Sereme Y, Mankouri F, et al. Basophil activation test with Aspergillus molecules: the case for ABPA. Front Allergy 2022; 3:898731.
Liu A, Chen W, Wei Y, et al. Comparison of diagnostic efficiency of detecting IgG and IgE with immunoassay method in diagnosing ABPA: a meta-analysis. BMC Pulm Med 2023; 23:374.
Dramburg S, Hilger C, Santos AF, et al. EAACI Molecular Allergology User's Guide 2.0. Pediatr Allergy Immunol 2023; 34: (Suppl 28): e13854.
Wang R, Eades C, Palmer M, et al. Aspergillus sensitisation detection using point-of-care lateral flow assay in moderate to severe asthma. Med Mycol 2023; 61:myad076.
Sehgal IS, Dhooria S, Soundappan K, et al. Comparison of three sample types for performing LDBio Aspergillus immunochromatographic technology lateral flow assay for IgG/IgM antibody detection in chronic aspergillosis. Clin Microbiol Infect 2023; 29:404–405.
Sehgal IS, Dhooria S, Prasad KT, et al. Comparative diagnostic accuracy of immunoprecipitation versus immunoassay methods for detecting Aspergillus fumigatus-specific IgG in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis. Mycoses 2022; 65:866–876.
Singh S, Choudhary H, Agnihotri S, et al. LDBio Aspergillus immunochromatographic test lateral flow assay for IgG/IgM antibody detection in chronic pulmonary aspergillosis: single-centre evaluation and meta-analysis. Indian J Med Microbiol 2022; 40:204–210.
Asano K, Hebisawa A, Ishiguro T, et al. New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis/mycosis and its validation. J Allergy Clin Immunol 2021; 147:1261.e5–1268.e5.
Singh A, Sadia Tomo U, Dodiya MK, et al. Clinical, microbiological, serological and radiological profile of patients with mild-moderate and severe allergic bronchopulmonary aspergillosis (ABPA). Cureus 2023; 15:e44662.
Qian X, Rong H, Wei X, et al. Value of CT radiomics combined with clinical features in the diagnosis of allergic bronchopulmonary aspergillosis. Comput Math Methods Med 2022; 2022:1–7.
Cottin V. Eosinophilic lung diseases. Immunol Allergy 2023; 43:289–322.
Agarwal R, Muthu V, Sehgal IS, et al. Allergic bronchopulmonary aspergillosis. Clin Chest Med 2022; 43:99–125.
Caminati M, Batani V, Guidolin L, et al. One-year mepolizumab for allergic bronchopulmonary aspergillosis: focus on steroid sparing effect and markers of response. Eur J Intern Med 2022; 99:112–115.